IP Library Patent Application 15001564
Patent Application
App. No. 15/001,564

TISSUE MATRICES WITH CONTROLLED POROSITY OR MECHANICAL PROPERTIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/001,564
Abstract

The present disclosure provides tissue products produced from extracellular tissue matrices. The tissue products can include acellular extracellular matrices that have been treated in select areas to increase the compressive modulus of the matrix in the selected area while maintaining the ability to support cell growth and tissue regeneration. In addition, the tissue products can include collagen-containing materials that support tissue ingrowth along with a framework of collagenous or polymeric materials such that the combination has a desired compressive or tensile modulus and/or strength while maintaining the ability to support cell growth and tissue regeneration.

Claims (32)

1 . A device for treatment of an anatomic defect, comprising:

a synthetic polymeric material substrate; and

an acellular tissue matrix embedding the synthetic polymeric substrate, wherein the acellular tissue matrix comprises an adipose tissue matrix.

2 . The device of claim 1 , wherein the synthetic polymeric material substrate comprises polypropylene.

3 . The device of claim 1 , wherein the synthetic polymeric material substrate is selected from at least one of polyurethanes, degradable polyesters, polyglycolic acid, polylactic acid, polycaprolactone, polytrimethylene carbonate and copolymers, polyanhydrides, polycarbonates, polyesteramides, polyphosphazenes, polyolefins, nondegradable polyesters, nylon, polyacrylates, silicones, tyrosine base polymers, polyhydroxyalkanoates, chitin, or chitosan.

4 . The device of claim 1 , wherein the acellular tissue matrix is formed by a process comprising:

selecting an adipose tissue;

treating the tissue to remove substantially all cellular material from the tissue;

suspending the tissue in a liquid to form a suspension;

placing the synthetic polymeric material substrate in the suspension; and

freezing and drying the suspension to form a porous sponge embedding the synthetic polymeric material substrate.

5 . The device of claim 4 , wherein the process further comprises stabilizing the porous sponge.

6 . The device of claim 5 , wherein stabilizing the porous sponge comprises cross-linking the porous sponge.

7 . The device of claim 5 , wherein stabilizing the porous sponge comprises subjecting the porous sponge to a dehydrothermal process.

8 . The device of claim 6 , wherein cross-linking the porous sponge comprises performing at least one of chemical cross-linking, cross-linking with e-beam radiation, cross-linking with gamma radiation, or cross-linking with ultraviolet radiation.

9 . The device of claim 1 , wherein the synthetic polymeric material substrate is a mesh.

10 . A method for producing a treatment device, comprising:

selecting an adipose tissue;

treating the tissue to remove substantially all cellular material from the tissue;

suspending the tissue in a liquid to form a suspension;

placing a synthetic polymeric material substrate in the suspension; and

freezing and drying the suspension to form a porous sponge embedding the synthetic polymeric material substrate.

11 . The method of claim 10 , wherein the synthetic polymeric material substrate comprises polypropylene.

12 . The method of claim 10 , wherein the synthetic polymeric material substrate is selected from at least one of polyurethanes, degradable polyesters, polyglycolic acid, polylactic acid, polycaprolactone, polytrimethylene carbonate and copolymers, polyanhydrides, polycarbonates, polyesteramides, polyphosphazenes, polyolefins, nondegradable polyesters, nylon, polyacrylates, silicones, tyrosine base polymers, polyhydroxyalkanoates, chitin, or chitosan.

13 . The method of claim 10 , wherein the process further comprises stabilizing the porous sponge.

14 . The method of claim 13 , wherein stabilizing the porous sponge comprises cross-linking the porous sponge.

15 . The method of claim 13 , wherein stabilizing the porous sponge comprises subjecting the porous sponge to a dehydrothermal process.

16 . The method of claim 14 , wherein cross-linking the porous sponge comprises performing at least one of chemical cross-linking, cross-linking with e-beam radiation, cross-linking with gamma radiation, or cross-linking with ultraviolet radiation.

17 . The method of claim 10 , wherein the synthetic polymeric material substrate is a mesh.

18 . A device for treatment of an anatomic defect produced by the process of claim 10 .

19 . A device for treatment of an anatomic defect produced by the process of claim 11 .

20 . A device for treatment of an anatomic defect produced by the process of claim 15 .

Assignments (6)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2016
From: JESSOP, ISRAEL; SHAH, MRINAL; LEAMY, PATRICK
To: LIFECELL CORPORATION
Reel/Frame 037744/0513 →